Product Information

MEMANTINE-DONEPEZIL ER 14-10 MG is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $6.1300 per EA under NDC 69238124803. Its NADAC has been published 70 times since Jul 23, 2025.

FDA first approved this application on Jan 27, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

MEMANTINE-DONEPEZIL ER 14-10 MG

Memantine and Donepezil
$6.1300per EA

Strength

10; 14 mg/1; mg/1

NDC

69238124803

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA208328

FDA Approved

1/27/2017

TE Code

AB

On Market Since

2/1/2017

Pharmacological Classes

Cholinesterase Inhibitor
Cholinesterase Inhibitors
N-methyl-D-aspartate Receptor Antagonist
NMDA Receptor Antagonists

Price Statistics

The NADAC for MEMANTINE-DONEPEZIL ER 14-10 MG has been published 70 times since Jul 23, 2025, and over the history we have for it it has declined 63.0%. The table below summarizes its recorded NADAC range and movement.

Current price$6.1300 per EA
All-time high$16.5827 (Aug 13, 2025)
All-time low$6.1300 (Nov 18, 2026)
52-week high$14.9939
52-week low$6.1300
Median price$11.8579
Average price$11.8989
Largest weekly change-13.1% (Aug 19, 2026)
Weeks tracked70
Tracking sinceJul 23, 2025

Price History

1W

-5.6%

1M

-5.5%

3M

-16.4%

6M

-39.0%

1Y

-59.1%

3Y

N/A

5Y

N/A

All

-63.0%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Memantine and Donepezil market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of MEMANTINE-DONEPEZIL ER 14-10 MG?

The current National Average Drug Acquisition Cost (NADAC) for MEMANTINE-DONEPEZIL ER 14-10 MG, manufactured by Amneal Pharmaceuticals NY LLC, is $6.1300 per EA (NDC 69238124803), effective Nov 18, 2026.

How has the price of MEMANTINE-DONEPEZIL ER 14-10 MG changed over time?

Over the history we have for it, the NADAC for MEMANTINE-DONEPEZIL ER 14-10 MG has declined 63.0%. It has been tracked across 70 weekly CMS publications since Jul 23, 2025.

What are the highest and lowest recorded NADAC prices for MEMANTINE-DONEPEZIL ER 14-10 MG?

Since Jul 23, 2025, the NADAC for MEMANTINE-DONEPEZIL ER 14-10 MG has ranged from a low of $6.1300 (Nov 18, 2026) to a high of $16.5827 (Aug 13, 2025), with a median of $11.8579 per EA.

Are there cheaper alternatives to MEMANTINE-DONEPEZIL ER 14-10 MG?

No other NADAC-published product currently shares the active ingredient and strength of MEMANTINE-DONEPEZIL ER 14-10 MG in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures MEMANTINE-DONEPEZIL ER 14-10 MG?

MEMANTINE-DONEPEZIL ER 14-10 MG (NDC 69238124803) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.